Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. (Q39472017)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 1999
edit
Language Label Description Also known as
English
Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.
scientific article published on October 1999

    Statements

    Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit